Transaction · 0001584759-26-000017

Heyman Richard A.

Heyman Richard A., DIR, reported a transaction classified as exercise at Oric Pharmaceuticals, Inc. involving 3500.000000 shares for an estimated $5600.00. Reported holdings after the transaction were 41800.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MDIR
ORICOric Pharmaceuticals, Inc.
Filing timeOct 02
Trade dateOct 01, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$12.20
Pre-filing
1mo ago +5.7%1w ago +8.0%1d ago +10.4%
Returns since
7d30d90d180d1y

ORIC price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ORIC since 2026-10-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001584759-26-000017
Common Stock
Transaction date
Oct 01, 2026
Filed Oct 02, 2026, 09:50 PM · 1d delay
Shares
3.50k sh
$1.60 per share
Estimated value
$5.60k
Computed from shares × price
Holdings after
41.8k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $12.57 to $13.39. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission…

  3. F3

    The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.

  4. F4

    The shares subject to the option are fully vested and immediately exercisable.

Original filing · 0001584759-26-000017
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ORIC